Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
2.710
+0.020 (0.74%)
At close: Nov 20, 2024, 4:00 PM
2.840
+0.130 (4.80%)
After-hours: Nov 20, 2024, 6:55 PM EST
Boundless Bio Market Cap
Boundless Bio has a market cap or net worth of $60.43 million as of November 21, 2024.
Market Cap
60.43M
Enterprise Value
-106.58M
1-Year Change
n/a
Ranking
Category
Stock Price
$2.71
Market Cap Chart
Since the IPO on March 28, 2024, Boundless Bio's market cap has decreased from $355.83M to $60.43M, a decrease of -83.02%. That is a compound annual growth rate of -93.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 59.98M | -83.14% |
| Mar 28, 2024 | 355.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Exagen | 61.37M |
| Aileron Therapeutics | 61.10M |
| Immuneering | 60.49M |
| Agenus | 60.29M |
| Entera Bio | 60.04M |
| Procaps Group | 59.68M |
| bluebird bio | 59.32M |
| Cellectar Biosciences | 57.72M |